Home > Drug Search >
  • company_query: Amplimmune
  •   > 
Drug Filter
Category:
chemistry (4) biology (28)
Status:
Approved (2) BLA Filing (2) Phase Ⅲ (3) Phase Ⅱ (14) Phase Ⅰ (11)
Clinical Stage:
Pending (2) Active (27) Discontinued (1)
Bio-Type:
Coagulation factor (2) Gene therapy (1) Vaccine (2) Blood extraction (1) Recombinant enzyme (1) Recombinant polypeptide (2) Recombinant hormone (2) Other recombinant protein (1) Whole antibody (11) ADC (1) Fusion protein (1)
Indication:
Non-alcoholic steatohepatitis (1) Allergic rhinitis (AR) (1) Anemia (1) Asthma (1) Atopic dermatitis (2) Breast cancer (1) Chronic lymphocytic leukemia (CLL) (2) Guillain-Barre syndrome (1) Diabetic nephropathy (1) Transplant rejection (1) Gastric cancer (1) HCV infection (1) HIV infection (1) Melanoma (2) Multiple myeloma (MM) (1) Myelodysplastic syndrome (MDS) (1) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin’s lymphoma (NHL) (1) Ovarian cancer (1) Pancreatic cancer (2) Peripheral  neuropathy (1) Postmenopausal osteoporosis (1) Pertussis (1) Psoriasis (1) Cellulite (1) Rheumatoid arthritis (RA) (1) Solid tumours (4) Thyroid cancer (1) Type 2 diabetes (2) Ulcerative colitis (1) Colorectal cancer (2) Chronic heart failure (1) Systemic inflammatory response syndrome (SIRS) (1) Type 1 diabetes (2) Hemophilia B (1) Sepsis (1) Glioblastoma (1) Allergic asthma (2) Musculoskeletal pain (1) Immunodeficiency disorders (1) Inflammation (2) Hemophilia (1) Immune thrombocytopenic purpura (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top